Approval · Notice of Compliance 10014 · 2009
NU-RANIT: Notice of Compliance 10014
Issued January 29, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10014
- Date
- January 29, 2009
- Company
- Nu-Pharm IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New formulation
- Therapeutic class
- Histamine H2 receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NU-RANIT | Not yet assigned | — |
Medicinal ingredients
- RANITIDINE HCL 150 MG per TAB
- RANITIDINE HCL 300 MG per TAB